Study
Undertaking an Advanced Biomedical Materials PhD with our CDT programme provides students with a foundation of important skills.
Recruitment
The final cohort for this programme has been recruited. Contact us to enquire about recruiting programmes.
As a student on the CDT, you'll develop strong links and networks that enable you to collaborate worldwide and enhance the future of UK biomedical materials.
You'll learn transferable skills such as project management, dissemination and multidisciplinary communication, as well as engaging with established industry partners and developing new industrial partnerships.
There's a socially responsible focus to our programme, as you'll take part in exciting outreach and widening participation activities with school children and the general public.
Unique training environment
Students benefit from an innovative research-training environment that is unique in the UK. Through the Henry Royce Institute Manchester, students have access to £4 million of specialist biomedical materials research equipment in the areas of bioelectronics, fibre technology, additive manufacturing and improved pre-clinical characterisation.
Since February 2020 an additional £8 million investment has been made in the same themes, which includes light sheet and in vivo confocal microscopes at the Henry Royce Institute Sheffield, as well as additive manufacture and biomechanics suite and novel fibre technology equipment at Manchester.
Responsible Research and Innovation (RRI)
RRI anticipates and assesses potential implications and societal expectations with regard to research and innovation. It aims to foster inclusive and sustainable research and innovation. Drawing on the EPSRC’s 'AREA' framework: Anticipate, Reflect, Engage and Act, our teaching covers the impact of research on others through the actions and decisions of researchers, whilst questioning how researchers take account of potential consequences.
Broad Spectrum Virucidal Antiviral Development research
PhD student Elana Super discusses her research on broad spectrum virucidal antiviral development.
